DIAXONHIT SPECIALTY DIAGNOSTIC SOLUTIONS
LIVE

Serial Number

79134609

Owner

DIAXONHIT

Filing Date

Mar 29, 2013

Add to watchlist:

No watchlists yet
View on USPTO

DIAXONHIT SPECIALTY DIAGNOSTIC SOLUTIONS Trademark

Serial Number: 79134609 • Registration: 4553916

DIAXONHIT SPECIALTY DIAGNOSTIC SOLUTIONS is a trademark filed by DIAXONHIT on March 29, 2013. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

DIAXONHIT (3 trademarks)

63-65 boulevard Massena
F-75013 PARIS , FR

Entity Type: 99

Trademark Details

Filing Date

March 29, 2013

Registration Date

June 24, 2014

Published for Opposition

April 8, 2014

Cancellation Date

March 29, 2023

Goods & Services

Pharmaceutical products for the treatment of diseases, namely, infectious diseases and Alzheimer disease and other neurodegenerative diseases and cancer; chemical and biological reagents for medical use for diagnostics, namely, chemical and biological reagents for use in tests based on blood or biological biomarkers enabling the identification of patients affected by diseases or being at risk of developing a disease and for enabling the identification of patients responding to specific personalized medical treatments; biological acidic products and preparations for pharmaceutical purposes, namely, pharmaceutical preparations for diagnosing diseases, namely, infectious diseases and Alzheimer disease and other neurodegenerative diseases and cancer; capsules sold empty for medicines and diagnostic tests; chemico-pharmaceutical preparations for diagnosing, preventing and treating diseases, namely, infectious diseases and Alzheimer disease and other neurodegenerative diseases and cancer; biopharmaceutical products for diagnosing, preventing and treating diseases, namely, infectious diseases and Alzheimer disease and other neurodegenerative diseases and cancer; chemical preparations for medical, pharmaceutical or veterinary purposes, especially chemical preparations for diagnosing diseases and in particular infectious diseases, neurodegenerative diseases and cancers; medical and clinical diagnostic products, namely, beads, microspheres, nucleic acid or antigen banks, nucleic acids, antigens on beads, or on microspheres, on biochips or on other media; DNA libraries, RNA libraries and antigen libraries, namely, biological materials in the nature of tissue and samples of blood for medical diagnosis and companion diagnosis for medical purposes; nucleic acid or antigen sequences, namely, biological materials intended for medical use and medical diagnosis, namely, for decoding the genes and proteins affected by diseases or revealing the transcriptomic signature of patients affected by diseases and for the detection of specific antibodies produced by patients affected by diseases; enzymes or enzyme preparations for medical or veterinary purposes, namely, enzyme stabilizers and enzymatic substrates for use as ingredients in medicines for the treatment of diseases; chemical reagents for medical use contained in diagnostic testing kits for collecting biological samples required for the preservation of the biological material under analysis to carry out the test in appropriate conditions

Medical services; veterinary services; medical assistance; consultancy in the field of biotechnology and pharmacy, namely, to assist in the selection of people suffering from diseases for clinical trials and to offer targeted care and personalized medical solutions; hospital services; services for the pharmaceutical industry and pharmacists, those who prepare prescriptions, namely, immunology, infectiology, cancerology, geriatric and neurological services, in order to facilitate diagnoses and undertaking therapy; health care services; telemedicine services

Surgical, medical, dental and veterinary apparatus and instruments, especially apparatus and instruments, namely, fluorescent instruments in the nature of fluorescent tracers and fluorescent dye and fluorescence microscope and X-ray fluorescence spectrometer used for identifying diseases, assessing the severity of these diseases, assessing prognoses of these diseases, measuring the progression of a disease; medical devices using beads, microspheres and fluorescent instruments, and biopsies for analyzing blood or other biological materials; apparatus for medical use for analyzing blood or other products of the human body; apparatus for medical diagnosis, namely, kits for taking samples of blood or other products of the human body comprising medical instruments for taking blood, DNA collection for diagnosing diseases, and materials required for the preservation of any product of the human body under analysis to carry out the test under good conditions; spoons for administering medicine; containers specially adapted to the application of medicines, namely, small bags and pouches used for administering medicines; probes for medical use; syringes for medical use; galvanic therapeutic appliances particularly for diagnosing diseases; probes and kits comprised of materials and medical instruments for taking blood samples, for collecting DNA and materials required for the preservation of the biological material under analysis in order to carry out the test under the appropriate conditions, namely, tubes, syringes and storage containers for medical and clinical diagnosis

Research and development for others of pharmaceutical molecules or biological markers for diagnostic purposes and medicines for treating diseases; chemical analysis; chemical research; chemistry services, namely, analysis of RNA genes, antigens, tissue and samples of blood or other biological materials; biotechnological project studies for identifying people suffering from diseases and to measure the severity of these diseases, the prognoses, progression and conversion of the disease and to determine the responsiveness of patients to treatments, especially personalized medical treatments; research and development of new products for others;biological research; biotechnological research; technical research in the field of biotechnology; biotechnological analysis services; laboratory analysis, namely, quantification of nucleic acid content intended for medical and scientific research

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Oct 22, 2023 DENC
DEATH OF INTERNATIONAL REGISTRATION
Oct 22, 2023 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Apr 3, 2022 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Feb 27, 2022 INTS
INVALIDATION PROCESSED
Feb 26, 2022 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 26, 2021 INTR
CANCELLED SECTION 71
Feb 26, 2021 C71T
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 23, 2015 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 9, 2014 FICS
FINAL DISPOSITION PROCESSED
Dec 9, 2014 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 24, 2014 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 24, 2014 R.PR
PUBLISHED FOR OPPOSITION
Apr 8, 2014 PUBO
NOTIFICATION PROCESSED BY IB
Apr 4, 2014 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 19, 2014 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 19, 2014 OP2R
NOTICE OF PUBLICATION
Mar 19, 2014 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 2, 2014 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 24, 2014 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 6, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 6, 2014 CRFA
ASSIGNED TO LIE
Feb 3, 2014 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 24, 2014 TROA
REFUSAL PROCESSED BY IB
Sep 23, 2013 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 4, 2013 RFCS
REFUSAL PROCESSED BY MPU
Sep 4, 2013 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 1, 2013 RFCR
NON-FINAL ACTION WRITTEN
Aug 31, 2013 CNRT
APPLICATION FILING RECEIPT MAILED
Aug 27, 2013 MAFR
ASSIGNED TO EXAMINER
Aug 23, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 23, 2013 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 22, 2013 REPR